Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5210732

CCOC(=O)c1c(C(N)=O)sc(C)c1C.NCc1cccc(C(=O)N(CC(=O)O)c2ccccc2)c1.O=C(O)C(F)(F)F

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.35
TP53 P04637 2/20 0.35
LMNA P02545 1/20 0.35
ALDH1A1 P00352 8/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
RAD52 P43351 1/20 0.34
NPSR1 Q6W5P4 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
FOLH1 Q04609 2/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
LOXL2 Q9Y4K0 1/20 0.33
HPGD P15428 4/20 0.33
KDM4E B2RXH2 3/20 0.33
SENP1 Q9P0U3 1/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5207834 0.87 PDE4D (0.41) MAPTTP53LMNAALDH1A1MEN1
Trifluoroacetic Acid SCHEMBL5209084 0.85 MAPT (0.32) MAPTTP53LMNAFOLH1HTT
Trifluoroacetic Acid SCHEMBL5208832 0.85 OPRM1 (0.35) MAPTTP53LMNAFOLH1HTT
Trifluoroacetic Acid SCHEMBL5208680 0.85 KDM4E (0.36) MAPTTP53LMNAALDH1A1FOLH1
Trifluoroacetic Acid SCHEMBL5217152 0.85 ALDH1A1 (0.37) MAPTTP53LMNAALDH1A1MEN1
Trifluoroacetic Acid SCHEMBL5209515 0.85 MAPT (0.40) MAPTTP53LMNAALDH1A1MEN1
Trifluoroacetic Acid SCHEMBL5206475 0.84 PTGER4 (0.34) MAPTTP53LMNAALDH1A1MEN1
Trifluoroacetic Acid SCHEMBL5210556 0.84 CXCR2 (0.43) LMNAALDH1A1MEN1KMT2AKDM4E
Trifluoroacetic Acid SCHEMBL5207793 0.84 PDE4D (0.40) MAPTTP53LMNAALDH1A1NPSR1
Trifluoroacetic Acid SCHEMBL5206983 0.84 MAPT (0.41) MAPTTP53LMNAALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1240154-B1 SERINE PROTEASE INHIBITORS TULARIK LTD (GB) 2007-02-28 EP disclosed
US-7157585-B2 Serine protease inhibitors TULARIK LIMITED (GB) 2007-01-02 US disclosed
US-20050215587-A1 Serine protease inhibitors LIVELY SARAH E 2005-09-29 US disclosed
US-6916957-B2 Serine protease inhibitors TULARIK LIMITED (GB) 2005-07-12 US disclosed
US-20030018059-A1 Serine protease inhibitors PROTHERICS MOLECULAR DESIGN LIMITED (GB) 2003-01-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215587-A1 Serine protease inhibitors PRSS1, TPSAB1, CMA1 MAPT 4112/4885TP53 3136/4885LMNA 563/4885
US-20030018059-A1 Serine protease inhibitors TPSAB1, PRSS1, SERPINB1 MAPT 4440/4885TP53 3993/4885LMNA 865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.